Search hospitals

>

Ohio

>

Cincinnati

Good Samaritan Hospital - Cincinnati

Claim this profile

Cincinnati, Ohio 45220

Global Leader in Breast Cancer

Global Leader in Lung Cancer

Conducts research for Breast cancer

Conducts research for Ovarian Cancer

Conducts research for Cancer

326 reported clinical trials

7 medical researchers

Photo of Good Samaritan Hospital - Cincinnati in CincinnatiPhoto of Good Samaritan Hospital - Cincinnati in CincinnatiPhoto of Good Samaritan Hospital - Cincinnati in Cincinnati

Summary

Good Samaritan Hospital - Cincinnati is a medical facility located in Cincinnati, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Ovarian Cancer, Cancer and other specialties. Good Samaritan Hospital - Cincinnati is involved with conducting 326 clinical trials across 531 conditions. There are 7 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, Patrick Muck, MD, and Mehmet S. Copur.

Area of expertise

1

Breast Cancer

Global Leader

Good Samaritan Hospital - Cincinnati has run 45 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
ER positive
2

Lung Cancer

Global Leader

Good Samaritan Hospital - Cincinnati has run 39 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage I

Top PIs

Clinical Trials running at Good Samaritan Hospital - Cincinnati

Bladder Cancer

Breast Cancer

Lung Cancer

Ovarian Cancer

Breast cancer

Esophageal cancer

Prostate Cancer

Cancer

Uterine Cancer

Multiple Myeloma

Image of trial facility.

Gemcitabine + Docetaxel vs BCG

for Bladder Cancer

This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.

Recruiting

2 awards

Phase 3

14 criteria

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

Recruiting

2 awards

Phase 3

Image of trial facility.

Gemcitabine + Cisplatin

for Bladder Cancer

This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Recruiting

1 award

Phase 2

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Good Samaritan Hospital - Cincinnati?

Where is Good Samaritan Hospital - Cincinnati located?

Who should I call to ask about financial aid or insurance network?

What insurance does Good Samaritan Hospital - Cincinnati accept?

What awards or recognition has Good Samaritan Hospital - Cincinnati received?